New research challenges concerns that tirzepatide harms the eyes, finding lower rates of diabetic retinopathy instead.
The Healthy @Reader's Digest on MSN
What I wish I’d known about cataract surgery: A doctor details what patients should know about a common procedure
An expert MD reveals clear insights into cataract surgery, spotlighting the breakthroughs in treatment: "We live in a time of ...
Please provide your email address to receive an email when new articles are posted on . Laser treatments, anti-VEGF injections and surgery can all be used to treat diabetic retinopathy. David Baxley, ...
Annexin Pharmaceuticals AB today announces a shortening of the ANXV treatment regimen from five to three days at the same dose level. A three-day treatment is expected to strengthen the commercial val ...
Intravitreal brolucizumab provides superior best-corrected visual acuity preservation and a higher rate of disease regression compared with panretinal photocoagulation laser surgery in patients with ...
An injection of 6 mg of intravitreal brolucizumab was at least as effective as — and potentially superior to — panretinal laser photocoagulation in preserving vision in patients with proliferative ...
Sequential navigated subthreshold micropulse yellow laser therapy performed 4 weeks after dexamethasone implantation improves visual and anatomical outcomes while extending retreatment-free intervals ...
A newly identified protein may hold the key to preventing diabetic blindness. Researchers discovered that LRG1 triggers the earliest damage in diabetic retinopathy by constricting tiny retinal blood ...
For prevention of diabetic retinopathy (DR) incidence or progression, the American Academy of Ophthalmology Preferred Practice Pattern (AAO PPP) and the American Diabetes Association Standards of Care ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results